Aspen Aerogels Analyst Price Targets - Benzinga

Aspen Aerogels Inc

ASPNNYSE

Trade with Public

Trade with Public

$4.93

-0.30-5.74%

At close: Aug 28, 5:00 PM EST

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

Aspen Aerogels Analyst Price Targets

Wall Street analyst price targets and consensus rating for Aspen Aerogels (ASPN).

Price Target Range — 12 Quarters

Analyst Consensus — 11 Analysts

9Buy

1Hold

1Sell

Consensus RatingBuy# Analysts11Avg. Consensus PT$19Upside to Avg. PT+287.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 11, 2026	Barclays	David Anderson	PT Raise	Underweight	$4→$5
May 11, 2026	Barclays	David Anderson	PT Raise	Underweight	$3→$4
Mar 5, 2026	Barclays	David Anderson	PT Cut	Underweight	$4→$3
Feb 26, 2026	TD Cowen	Itay Michaeli	PT Cut	Buy	$7→$6
Feb 26, 2026	Roth Capital	Chip Moore	PT Cut	Buy	$6→$3
Nov 7, 2025	Canaccord Genuity	George Gianarikas	PT Cut	Buy	$10→$5
Nov 7, 2025	Barclays	David Anderson	PT Cut	Underweight	$6→$4
Aug 11, 2025	Barclays	David Anderson	Downgrade	Equal-Weight→Underweight	$7→$6
Aug 8, 2025	Canaccord Genuity	George Gianarikas	PT Cut	Buy	$11→$10
May 29, 2025	Barclays	David Anderson	Downgrade	Overweight→Equal-Weight	$13→$7
Feb 19, 2025	B. Riley Securities	Ryan Pfingst	PT Cut	Buy	$35→$22
Feb 19, 2025	Barclays	David Anderson	PT Cut	Overweight	$25→$13
Feb 14, 2025	Roth MKM	Chip Moore	PT Cut	Buy	$22→$16
Feb 14, 2025	Canaccord Genuity	George Gianarikas	PT Cut	Buy	$20→$15
Feb 14, 2025	Craig-Hallum	Eric Stine	PT Cut	Buy	$21→$18
Feb 13, 2025	Seaport Global	Tom Curran	Downgrade	Buy→Neutral	—
Jan 24, 2025	Craig-Hallum	Eric Stine	PT Cut	Buy	$30→$21
Jan 16, 2025	Canaccord Genuity	George Gianarikas	PT Cut	Buy	$28→$20
Nov 12, 2024	Barclays	David Anderson	PT Cut	Overweight	$27→$25
Nov 8, 2024	Roth MKM	Chip Moore	PT Cut	Buy	$36→$31

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Barclays Maintains Underweight on Aspen Aerogels, Raises Price Target to $5

Barclays analyst David Anderson maintains Aspen Aerogels (NYSE:ASPN) with a Underweight and raises the price target from $4 to $5.

Benzinga Newsdesk

PRO
Barclays Maintains Underweight on Aspen Aerogels, Raises Price Target to $4

Barclays analyst David Anderson maintains Aspen Aerogels (NYSE:ASPN) with a Underweight and raises the price target from $3 to $4.

Benzinga Newsdesk

PRO
TD Cowen Maintains Buy on Aspen Aerogels, Lowers Price Target to $6

TD Cowen analyst Itay Michaeli maintains Aspen Aerogels (NYSE:ASPN) with a Buy and lowers the price target from $7 to $6.

Benzinga Newsdesk

PRO
Roth Capital Maintains Buy on Aspen Aerogels, Lowers Price Target to $3

Roth Capital analyst Chip Moore maintains Aspen Aerogels (NYSE:ASPN) with a Buy and lowers the price target from $6 to $3.

Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Buy on Aspen Aerogels, Lowers Price Target to $5

Canaccord Genuity analyst George Gianarikas maintains Aspen Aerogels (NYSE:ASPN) with a Buy and lowers the price target from $10 to $5.

Benzinga Newsdesk

PRO
Barclays Maintains Underweight on Aspen Aerogels, Lowers Price Target to $4

Barclays analyst David Anderson maintains Aspen Aerogels (NYSE:ASPN) with a Underweight and lowers the price target from $6 to $4.

Benzinga Newsdesk